GILEAD SCIENCES, INC. (GILD)
Clinical trial NCT06060665 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2026-06-01 → 2026-05-06 3. primary completion date: 2026-06-01 → 2026-05-06 4. enrollment: 90 → 96 participants 5. enrollment type: ESTIMATED → ACTUAL
📉 **NEGATIVE** • Medium confidence analysis (68%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical